Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Response of Recombinant Antithrombin in Heparin Resistant Patients
NCT01547728Phase 4Terminated
- Sponsor
- Mayo Clinic
- Start
- Feb 2012
- Primary completion
- Feb 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of antithrombin III in heparin resistance, antithrombin III deficiency, sponsored by Mayo Clinic. Started Feb 2012; status: terminated.
02
Drugs
antithrombin III
03
Conditions
heparin resistanceantithrombin III deficiency
Beyond the preview
Go deeper on NCT01547728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01547728.